Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart failure
Pharma
Novartis wins 11th-hour bid to block Entresto generic from MSN
Novartis' roller-coaster ride with Entresto has taken another zig with a U.S. appellate court blocking the sale of MSN's generic.
Kevin Dunleavy
Jan 17, 2025 11:41am
Letting go of Armgo: Biotech rebrands as RyCarma Therapeutics
Jan 7, 2025 3:20pm
Wegovy and Zepbound tipped to fuel $20B heart failure boom
Jan 7, 2025 11:12am
Look out, Pfizer: BridgeBio gains 'best-case' FDA nod for Attruby
Nov 25, 2024 7:59am
FDA expert panel spurns Lexicon's approval bid in type 1 diabetes
Nov 1, 2024 11:24am
Judge upholds MSN's generic Entresto nod amid Novartis challenge
Oct 17, 2024 2:59pm
